Bloodstream infections caused by Klebsiella pneumoniae jumped 72% between 2019 and 2025 – far short of the EU's target of slashing them by 5% by 2030, according to the European Centre for Disease Prevention and Control.
Some strains of the deadly bacterium spreading through European hospitals have become resistant to almost every available antibiotic, including newer drugs, warns the ECDC.
the bacterium poses a particularly serious threat to hospital patients, with associated infections carrying mortality rates of 40–70%
Unlike some better-known hospital superbugs, Klebsiella can persist in the human gut, making transmission harder to prevent, requiring stricter hygiene, protective equipment and hospital disinfection
ECDC specialist Christian Giske called the findings the agency's “biggest concern” among Europe's growing superbug threats
Other infections are also rising, as drug-resistant E. coli infections increased 16.4% over the same period, despite the EU's target of cutting them by 10% by 2030.
Antimicrobial resistance , when bacteria evolve to survive drugs designed to kill them, is estimated to claim 35,000 lives annually across the EU, Iceland and Norway.
Source of information: Global News Agencies including REUTERS / TASS / AFP / AP / ANADOLU / INT.RU / Al Jazeera / CNN
Politico: una «superbacteria», resistente incluso a los antibióticos modernos, se propaga rápidamente en los hospitales de Europa.
ReplyDeleteLa Klebsiella pneumoniae es cada vez más difícil de tratar. El número de infecciones por esta bacteria ha crecido en los últimos años. Las infecciones asociadas a ella representan una grave amenaza para los pacientes y tienen una alta tasa de mortalidad, normalmente del 40 al 70%.
La bacteria, entre otras cosas, puede causar neumonía, meningitis e infecciones del torrente sanguíneo.